DCSIMG

UL graduate secures prestigious research fellowship

Dr Claire Meaney has won a prestigious fellowship in the United States [Picture: Alan Place]

Dr Claire Meaney has won a prestigious fellowship in the United States [Picture: Alan Place]

 

A LIMERICK researcher has won a prestigious fellowship in the United States that she hopes to one day apply to the fight against cancer back home.

Claire Meaney achieved a first class honours degree in biomedical engineering at the University of Limerick before going on to complete a PhD in vascular tissue engineering last November.

She has remained at UL, where she is currently engaged in cancer research at the Materials and Surface Science Institute, work that allows her to combine her twin passions for engineering and biology.

But Dr Meaney will have to swap the river Shannon for the Potomac for now as she has been awarded a position on the Cancer Prevention Fellowship Programme, based in the National Cancer Institute in Maryland. She is the only Irish candidate to have secured a place on this programme in 2014 and the first UL graduate to receive this fellowship.

Speaking about the significance of the award, Dr Meaney said “the latest figures predict one in three people in Ireland will develop cancer during their lifetime”.

“Considering the on-going drive to advance cancer prevention, the training and experience I will gain at the NCI during this fellowship programme will greatly advance my future contribution towards cancer prevention and control in Ireland.”

The NCI programme trains post-doctorate researchers from the health professions, biomedical, and behavioural sciences to become leaders in the fields of cancer prevention and control.

Dr Meaney’s fellowship is co-sponsored by the Health Research Board in Ireland and the US Cancer Prevention Fellowship Programme.

Upon completion of this fellowship, Claire will be given the opportunity to bring this knowledge back to the Irish research and healthcare systems with support from the HRB and the Irish Cancer Society.

 

Comments

 
 

Back to the top of the page